What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“CaNCURE has granted me the opportunity to conduct independent cancer research, by providing me with a strong foundational education in nanomedicine as well as exceptionally experienced mentorship.”

Joseph Nneji, Biochemistry, ’16


Trainee Spotlight


Kevin Lin

Health Science, '21

Granzyme B Peptide as a Non-invasive Theranostic Agent

Mahimasri Kotamreddy

Biology and Mathematics, '21

Understanding the Role of Epigenetics in Multiple Myeloma Progression

Marina Yamada

Health Science, '21

Triple-targeted Photonanomedicine: A Strategy to Treat Heterogeneous Tumors

Featured Trainee Publication


Upcoming Events

Check back soon for new events


Mentor Spotlight


James A DeCaprio, M.D.

Professor of Medicine,

Using targeted mouse models, our lab studies host cell proteins that interact with polyoma virus oncoproteins. Students will study host perturbations following the systemic administration of synthetic viral nano-complexes in order to identify novel tumor suppressors and oncogenes in Merkel cell carcinoma.


Cesar Martin Castro, M.D.

Instructor in Medicine, MGH

Our research seeks to bridge current needs in clinical oncology with novel nanosensing technologies to selectively detect and profile cancer cells and tissues. Students will examine the feasibility of using magneto-DNA nanoparticles to characterize rare cancer cells in unpurified human clinical samples including ascites and blood.


Trainee Spotlight


Rodrigo Blanco Bravo

Bioengineering, '22

Multiplexed cellular fluorescent imaging in head and neck squamous cell carcinomas (HNSCC) for different markers to predict patient specific response rates to immunotherapy and for mapping of the tumor microenvironment (TME).

Hannah Curtis

Health Science, '21

The Role of CD8+ and CD4+ in the Tumor Microenvironment (TME) after Controlled Exercise in E0771/M3C Breast Cancer Models

Courtney Fraser

Health Science, '21

The Development and Characterization of Monoclonal Antibodies for Integrins and TGF-b


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...